Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis.

European journal of histochemistry : EJH

Volumn 41 Suppl 2, Issue , 1997, Pages 73-74

  Faretta, M ^a   Bergamaschi, D ^a   Ronzoni, S ^a   D'Incalci, M ^a   Erba, E ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE; CYCLIN B; CYCLIN B1; DISTAMYCIN A; TALLIMUSTINE;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MITOSIS; TIME;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CYCLIN B; DISTAMYCINS; FLOW CYTOMETRY; G2 PHASE; HUMANS; JURKAT CELLS; MITOSIS; NITROGEN MUSTARD COMPOUNDS; TIME FACTORS;

EID: 0031291949     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)